The recall includes about 355,000 8.4% sodium bicarbonate injection vials, 23,000 midazolam in 0.8% sodium chloride injection vials, and 38,000 cysteine hydrochloride injection vials.
Exela and Civica alerted customers of the issue in late October.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.